Decoy Therapeutics (DCOY) Total Debt (2018 - 2026)
Decoy Therapeutics (DCOY) posted quarterly Total Debt of $140000.0 for Q1 2026, little changed quarter-over-quarter from $140000.0 in Q4 2025.
Decoy Therapeutics (DCOY) Total Debt (2018 - 2026) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Total Debt for 4 consecutive years, with $140000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Debt changed N/A year-over-year to $140000.0; the TTM figure through Mar 2026 stood at $140000.0 (changed N/A YoY), while the FY2025 annual figure was $140000.0, changed N/A from the prior year.
- Total Debt held at $140000.0 in Q1 2026 per DCOY's latest filing, from $140000.0 in the prior quarter.
- Across five years, Total Debt topped out at $140000.0 in Q4 2025 and bottomed at $140000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 9.34 Bn |
| 10 | Decoy Therapeutics | 1.73 Mn | 1.73 Mn | - | 140,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 140,000.00 |
| Mar 31, 2026 | 140,000.00 |
| Dec 31, 2025 | 140,000.00 |
| Sep 30, 2019 | 4,429.00 |
| Dec 31, 2018 | 5,946.00 |